Friday, September 13, 2013

Visterra Shows Neutralization of H5N1 & H7N7 in Preclinical Results

September 12, 2013

Visterra Announces an Oral Presentation of VIS410 Data that Showed Neutralization of H5 and H7 Influenza Strains with Pandemic Potential Preclinical results presented at ICAAC 2013 demonstrated the ability of VIS410 to neutralize influenza strains with pandemic potential, H5N1 and H7N9 VIS410, a novel engineered human antibody against seasonal and pandemic flu, is advancing to the clinic in 2014

No comments: